SCHEMBL873570

SCHEMBL873570

O=C(O)C(=O)C1CCCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.67
CES1 P23141 1/20 0.67
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TSHR P16473 3/20 0.40
ALDH1A1 P00352 1/20 0.40
SLC6A1 P30531 2/20 0.37
SLC6A11 P48066 1/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SLC6A13 Q9NSD5 1/20 0.37
HSD11B1 P28845 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.35
NOS2 P35228 1/20 0.35
EPHX1 P07099 1/20 0.34
RECQL P46063 1/20 0.34
SRD5A2 P31213 1/20 0.34
HAO1 Q9UJM8 1/20 0.34
CHRNB2 P17787 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11305314 0.97 CES2 (0.63) CES2CES1HDAC8HDAC6TSHR
Water SCHEMBL27559365 0.97 CES2 (0.63) CES2CES1HDAC8HDAC6TSHR
SCHEMBL6159646 0.97 CES2 (0.72) CES2CES1HDAC8HDAC6TSHR
SCHEMBL18199938 0.97 CES2 (0.72) CES2CES1HDAC8HDAC6TSHR
SCHEMBL2650157 0.97 CES2 (0.72) CES2CES1HDAC8HDAC6TSHR
SCHEMBL25248339 0.97 CES2 (0.63) CES2CES1HDAC8HDAC6TSHR
Water SCHEMBL27570807 0.94 CES2 (0.68) CES2CES1HDAC8HDAC6TSHR
SCHEMBL873874 0.94
Methyl Alcohol SCHEMBL909941 0.92 CES2 (0.65) CES2CES1HDAC8HDAC6TSHR
Benzene SCHEMBL27623531 0.92 CES2 (0.65) CES2CES1HDAC8HDAC6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129398-A1 POLYPEPTIDE AND METHOD FOR PRODUCING AMINO ACID USING SAME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-04-24 US claimed
CN-118401654-A Polypeptide and method for preparing amino acid using same 中外制药株式会社 2024-07-26 CN claimed
WO-2023127752-A1 POLYPEPTIDE AND METHOD FOR PRODUCING AMINO ACID USING SAME 中外製薬株式会社 2023-07-06 WO claimed
EP-4206322-A2 POLYPEPTIDE AND METHOD FOR PRODUCING AMINO ACID USING SAME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-07-05 EP claimed
EP-2822682-B1 MICROCAPSULES AND USES THEREOF FIRMENICH & CIE (CH) 2017-04-26 EP claimed
CN-104994732-A Composition comprising peroxyacid CHD BIOSCIENCE INC 2015-10-21 CN claimed
EP-2643000-A2 THERAPEUTIC PIPERAZINES Dart Neuroscience (Cayman) Ltd (KY) 2013-10-02 EP claimed
WO-2012040258-A2 THERAPEUTIC PIPERAZINES HELICON THERAPEUTICS, INC. (US) 2012-03-29 WO claimed
US-20110065691-A1 THERAPEUTIC PIPERAZINES DART NEUROSCIENCE (CAYMAN) LTD. (KY) 2011-03-17 US claimed
US-7550277-B2 D-amino acid dehydrogenase and method of making D-amino acids CODEXIS, INC. (US) 2009-06-23 US claimed
US-20080182972-A1 D-amino acid dehydrogenase and method of making D-amino acids INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT 2008-07-31 US claimed
EP-1896574-A2 D-AMINO ACID DEHYDROGENASE AND METHOD OF MAKING D-AMINO ACIDS BioCatalytics Inc. (US) 2008-03-12 EP claimed
WO-2006113085-A2 D-AMINO ACID DEHYDROGENASE AND METHOD OF MAKING D-AMINO ACIDS BIOCATALYTICS, INC. (US) 2006-10-26 WO claimed
US-20250369029-A1 METHOD FOR PRODUCING AMINO ACID AND PEPTIDE COMPOUND, USING ENZYME AND ADDITIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2025-12-04 US disclosed
US-20250129398-A1 POLYPEPTIDE AND METHOD FOR PRODUCING AMINO ACID USING SAME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-04-24 US disclosed
EP-4520829-A1 METHOD FOR PRODUCING AMINO ACID AND PEPTIDE COMPOUND, USING ENZYME AND ADDITIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2025-03-12 EP disclosed
US-5654322-A HYPOTENSIVE AGENTS, CEREBRAL APOPLEXY WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1997-08-05 US disclosed
EP-0656355-A1 BIPHENYLMETHANE DERIVATIVE AND MEDICINE CONTAINING THE SAME WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1995-06-07 EP disclosed
US-4369206-A HARDENING COATING WITH AMINES BAYER AKTIENGESELLSCHAFT (DE) 1983-01-18 US disclosed
EP-0008626-A1 Ammonium salts of alpha-ketocarboxylic acids, their use in the preparation of amines and coating materials containing them BAYER AG (DE) 1980-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065691-A1 THERAPEUTIC PIPERAZINES PDE4A, PDE4B, PDE4D CES2 584/4885CES1 743/4885HDAC8 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.